Displaying 1 - 1 of 1
| Active Ingredient | FLUCONAZOLE |
| Therapeutic Class | AZOLES |
| Indications | Treatment of orophary ngeal and esophageal candidiasis, systemic candidal infections, vaginal candidasis, urinary tract infections, pneumonia, and peritonitis. Also, acquired immunodeficiency syndrome More ... |
| Caution | Nausea, vomiting, diarrhoea, elevations in liver functions tests and alopecia. Low dose does not appear to increase risk of congenital abnormalities in t he first trimester. |
| Dose Range |
Oropharyngeal and esophageal candidiasis: 200mg on day 1 then 100mg PO/IV daily for at least 2 weeks. Systemic candidiasis: 400mg PO/IV once daily for 4 weeks and for at least 2 weeks orally after resolution of symptoms. Vaginal candidiasis: 150mg ora |
| Drug Interactions | Clindamycin, Calcium channel blockers, Phenothiazines and Tricyclic antidepressants - increased risk of cardiotoxicity. Simvastatin and Cerivastatin - increased risk of Rhabdomyolysis. Amlodipi More ... |
| Pregnancy | Avoid use in pregnancy. Multiple congenital abnormalities has been reported with More ... |
| Breast Feeding |